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Abstract 
Background: Metastatic angiosarcoma to the brain is a rare entity without an established 
management protocol.  
Case description: The authors describe a case of primary cardiac angiosarcoma with a rare brain 
metastasis in an adult. This patient underwent successful resection of his brain metastasis and was 
initiated on only chemotherapy for his systemic disease. The patient did not develop local 
recurrence. A review of primary and metastatic CNS angiosarcoma, its pathologic features, clinical 
disease course, treatment strategies and genomics is also described. 
Conclusions: Angiosarcomas are rare tumors that remain difficult to treat. Gross total resection of a 
CNS metastasis is recommended prior to the initiation of adjuvant chemotherapy or radiation 
therapy. Close follow-up is still required given the propensity for these tumors to continue 
metastasis. Future treatments may be developed based on the genomics of angiosarcomas. 
Acknowledgement- none 
Funding Sources - This research did not receive any specific grants from funding agencies in the 
public, commercial, or non-for-profit sectors. 
2. Introduction
CNS angiosarcoma is a rare entity with a described incidence of less than 1% of all sarcomas. 1,2 
Here we describe a case of an adult that presented with a brain hemorrhage with multiple tumors 
involving the right atrium of the heart, lung, and spine. The patient was ultimately diagnosed with 
metastatic angiosarcoma after craniotomy and was initiated on systemic chemotherapy. Our purpose 
is to describe this case and review the literature on primary CNS and metastatic angiosarcoma. 
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3.  Case Report 
3.1.  History 
A 63 year old male presented to our emergency room with new right arm weakness and a 
hemorrhagic mass in his left frontal lobe on CT. The brain MRI revealed a 2 centimeter 
heterogeneously-enhancing, well demarcated left frontal lesion with surrounding vasogenic edema. 
(Figure 1) Several additional punctate contrast enhancing lesions as well as FLAIR-signal 
abnormality were present supra- and infratentorially. A CT-chest-abdomen and pelvis demonstrated 
multiple pulmonary nodules, a right atrial appendage mass, and a right T10 pathologic transverse 
process fracture. A lung core biopsy of a pulmonary nodule did not confirm a diagnosis, but did 
demonstrated atypical spindle cells with increased mitotic figures. Given the new neurologic deficit 
and the lack of diagnostic tissue, the patient underwent a left frontal craniotomy for tumor resection. 
3.2.  Neurosurgical Operation and Pathology 
At surgery, the tumor was noted to have black coloration with distinct margins and firm 
consistency. It was easily identified and removed en-block to avoid hemorrhage. Pathologic 
evaluation was significant for a tumor composed of anastomosing vascular channels lined with 
malignant endothelial cells. Areas of necrosis, and hemorrhage were also present. The tumor cells 
were positive for CD31 and CD34 with immunohistochemistry. (Figure 2) The CNS tissue matched 
the lung biopsy tissue and represented metastatic angiosarcoma. Given the propensity of 
angiosarcomas to originate from the right atrium, his right atrial mass was presumed to be the 
primary source. 
3.3.  Post-operative Course 
The patient regained strength in his right upper extremity post-operatively. The cardiothoracic 
surgery team was consulted and did not recommend resection of his right atrial appendage mass. He 
was ultimately discharged to an acute rehabilitation facility on post-operative day 7. Gemcitabine, 
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docetaxel and bevacizumab chemotherapy was initiated and he underwent a total of 7 cycles over 
10 months. Radiation therapy to the T10 metastasis was performed 4 months post-operatively. A 3 
and 7-month body CT-scan and MRI of the brain demonstrated interval size decreases of the lung 
metastasis and no additional brain metastasis. However, a repeat brain MRI at 10 months 
demonstrated new sub-centimeter brain metastasis in the right frontal lobe. The patient decided to 
continue monitoring this lesion while on chemotherapy and remains alive 12 months after surgery. 
4.  Discussion 
We describe a case of a cardiac angiosarcoma with multiple metastasis to the lung, spine, and brain. 
Primary and metastatic CNS angiosarcomas are a rare malignancy with an incidence rate less than 
1%1-4 Described risk factors for angiosarcoma include vinyl chloride, irradiation, chemotherapy, 
arsenic and thorotrast-contrast.1,5-8 In published case reports of angiosarcoma of the CNS, the 
clinical presentation is often rapid onset of neurologic deficits with intracranial hemorrhage. 9-13 The 
propensity of angiosarcomas to hemorrhage is underscored by a report of surgical resection that 
required 12 units of packed red blood cell and plasma transfusions.4  
Systemic angiosarcomas originate from endothelial cell of arteries, veins, or lymphatic channels.5,14 
Similarly, primary CNS angiosarcomas originate from the mesenchymal elements of the brain.3-
6,10,11,15-27
. The pathologic features of angiosarcomas consist of malignant spindle cells lining 
vascular channels with hemorrhage and necrosis.7,18,26 The endothelial origin of angiosarcomas is 
often confirmed with Factor VIII-related antigen, CD34 and/or CD31 
immunohistochemistry.7,16,18,19,21,28 Electron microscopy often shows tumors cells with irregular-
nuclei, rich endoplasmic reticulum, pinocytic vesicles and projections into the vascular 
lumen.5,11,14,18-20 Weibel-Palade bodies can also be identified within the endothelial cells on electron 
microscopy.17,20,29 Our patient’s tissue pathology was consistent with the diagnosis of metastatic 
angiosarcoma (Figure 2). 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 5
For metastatic CNS angiosarcoma, Shweikeh et al reported an average patient age of 42.3 years 
with 70% male predominance.2 Primary sites of disease have included the heart, aorta, femur, 
placenta, spleen, liver and scalp. 7-9,12,19,28-40 The most common primary site of angiosarcomas with 
CNS metastasis is the right atrium of the heart (35% of reported cases). 8,9,12,13,28,30,35,40 The most 
common metastasis sites are the cervical lymph nodes, lung, liver and spleen. 7,41 In our patient, we 
suspect that the primary site was the right atrial mass, with metastatic spread to the lung and brain.  
The diagnosis of angiosarcoma is grim. Reported overall 2-year and 5-year survival following a 
diagnosis of angiosarcoma is 17% and 12%, respectively. 2,7 In a case series of 8 patients with 
primary CNS angiosarcoma, mean survival was 8 months. 11 Merimsky et al describe three cases of 
primary CNS angiosarcoma with survival of 2.5, 5 and 20 months.3 Similar poor mortality rates 
have been described with metastatic CNS angiosarcoma with an average overall survival of 4.8 
months after diagnosis. 2,34,37,38,40Despite this, case reports of long-term survivors following 
craniotomy have been reported.4,11,15,22,23  A recent paper demonstrated spontaneous regression of 
metastatic angiosarcoma.42 
Gross total resection has been recommended as first-line treatment for both primary and metastatic 
CNS angiosarcoma given the propensity of these tumors to recur.15,30 Adjuvant treatment options 
include chemotherapy, radiation therapy and local brachytherapy. However, a standardized protocol 
has not been established. Moreover, a review of 99 cases of angiosarcoma demonstrated that often 
no treatment for these patients was undertaken.7 One reason may be because gross total resection is 
often difficult given the size and multiplicity of these tumors, as well as their propensity to 
hemorrhage. 13,42 Secondly, sarcomas are radioresistant. Mean survival following whole brain 
radiation for CNS sarcomas is 3 months.13 Stereotactic radiosurgery is also minimally effective for 
sarcomas. 43,44 Finally, use of chemotherapy agents such as paclitaxel, gemicitabine, bevacizumab, 
sorafenib, and docetaxel have been used against angiosarcoma. 42,45-49 However, angiosarcomas 
have been partially resistant to these chemotherapies, with most reported time-to-progression 
remaining under 12 months and overall survival ranging from 6 to 15 months. 42,45-49 These data 
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reflect the difficulty in treating angiosarcoma. Regardless, using each of these treatment modalities 
in combination has been recommended given the tumor’s malignant features.15,22,28 
Genomic studies of angiosarcoma have been reported. Zhrebker et al reported a case of a 56 year 
old male with metastatic angiosarcoma who underwent postmortem whole exome sequencing. They 
discovered the patient had a KDR mutation, a vascular-specific tyrosine kinase receptor, resulting in 
its overactivation.50 KDR mutations in angiosarcoma patients has been reported to have a 10% 
incidence and the whole exome sequencing study supported the potential clinical efficacy of a KDR 
inhibitor. 51Other genomic studies have demonstrated an upregulation of p53, Ras, BRCA, PTEN, 
and MYC in angiosarcomas. 52,53 Morphoproteomic studies of angiosarcoma patients demonstrated 
constitutive activation of (1) the signal transducer and activator of transcription (STAT3) pathway, 
(2) the ras/Raf kinase/extracellular signal-regulated kinase (ERK) pathway, (3) the hypoxia 
pathway, (4) the sonic hedgehog pathway, and (5) the mechanistic target of rapamycin (mTOR) 
pathway. 52,54 While these studies provide insight into the different oncogenic pathways utilized by 
angiosarcomas, the multiplicity of these pathways underscore the difficulty in effectively treating 
these tumors. 
5.  Conclusion 
CNS angiosarcoma is a rare and aggressive disease that is resistant to chemotherapy and radiation 
therapy. Genomic studies of angiosarcoma suggest its uses multiple oncogenic pathways to promote 
its growth. Here, we present a patient with a primary cardiac angiosarcoma and extensive metastatic 
angiosarcoma with CNS involvement. Our patient underwent surgical resection of his CNS lesion 
and adjuvant chemotherapy, which is consistent with prior literature recommendations. Our patient 
remains alive 12 months after craniotomy without local tumor recurrence. 
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 Figure Legends 
Figure 1- T1 and T1-post-contrast sequences demonstrate a heterogeneous enhancing mass in the 
left middle frontal lobe. The Head CT demonstrates hemorrhage within the mass. 
Figure 2- H&E stain at 4x demonstrates multiple vascular channels with areas of necrosis. The 
tumor cells were positive for CD31 and CD34 with immunohistochemistry. 
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Highlights 
• We describe a patient with metastatic angiosarcoma to the brain who underwent 
craniotomy and chemotherapy and remains alive 1 year after diagnosis. 
• Metastatic CNS angiosarcoma is a rare entity with no standardized treatment regimen. 
• Gross total resection of metastatic CNS angiosarcoma is recommended prior to adjuvant 
therapy, although close follow-up is still required given the propensity of these tumors 
to recur locally. 
